In an attempt to find a potentially useful serum marker in rheumatoid
arthritis (RA) which reflects underlying pathogenic mechanisms, we mea
sured the circulating levels of matrix-degrading metalloproteinase-9 (
MMP-9), also termed gelatinase B, in sera and synovial fluid (SF) from
patients with RA and also quantitated the deposition and local synthe
sis of MMP-9 in RA synovium. Clinical samples, subjected to gelatin su
bstrate zymography, antigenic immunoassay, and a quantitative substrat
e degradation assay, revealed elevated 92- and 72-kDa proenzyme forms
of MMP-9 and MMP-2 in RA sera and SF compared with healthy controls. I
mmunostaining on fresh RA synovial specimens revealed MMP-9 within vas
cular walls in fibroblast-like cells and macrophages; mRNA synthesis w
as detected using reverse transcriptase in situ PCR. In summary, MMP-9
levels are substantially elevated in the sera and SF from patients wi
th RA. The RA synovium is a source of this MMP-9 production, with abun
dant mRNA and protein observed within several different type of rheuma
toid synovial cells. (C) 1996 Academic Press, Inc.